APPLICATION
ANDA216725
TYPE
ANDA
ORIGINAL APPROVAL
2022-09-22
LATEST ACTION
2023-06-30
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
TOBRAMYCINPrescription
TOBRAMYCIN 300MG/4ML · SOLUTION · INHALATION
Approval history
2023-06-30Labeling · Supplement 2 · standardAP
2022-09-22UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.